This company listing is no longer active
Bioscience Neutraceuticals Past Earnings Performance
Past criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products Industry Growth | 20.9% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2019 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Bioscience Neutraceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 19 | 0 | -1 | 0 | 0 |
| 30 Sep 19 | 0 | 0 | 0 | 0 |
| 30 Jun 19 | 0 | 0 | 0 | 0 |
| 31 Mar 19 | 0 | -1 | 0 | 0 |
| 31 Dec 18 | 0 | 0 | 0 | 0 |
| 30 Sep 18 | 0 | 0 | 0 | 0 |
| 30 Jun 18 | 0 | 0 | 0 | 0 |
| 31 Mar 18 | 0 | 0 | 0 | 0 |
| 31 Dec 17 | 0 | 0 | 0 | 0 |
| 30 Sep 17 | 0 | 0 | 0 | 0 |
| 30 Jun 17 | 0 | 0 | 0 | 0 |
| 31 Mar 17 | 0 | 0 | 0 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
| 30 Sep 16 | 0 | 0 | 0 | 0 |
| 30 Jun 16 | 0 | 0 | 0 | 0 |
| 31 Mar 16 | 0 | 0 | 0 | 0 |
| 31 Dec 15 | 0 | 0 | 0 | 0 |
Quality Earnings: Insufficient data to determine if DEVV has high quality earnings.
Growing Profit Margin: Insufficient data to determine if DEVV's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if DEVV's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare DEVV's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if DEVV's earnings growth over the past year exceeded the Personal Products industry average.
Return on Equity
High ROE: DEVV has a negative Return on Equity (0%), as it is currently unprofitable.